Listen
Newsletters
Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media
Home
Bias Split
Public Figures
Controversies
Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters
Sign Up!
Sign Up Now!
How our sliders work
About
Contact Us
Newsletter Archive
Media
FAQ
Glossary
Privacy Policy
HIV
The U.S. Food and Drug Administration (FDA) approved Lenacapavir — a twice-yearly injectable drug to prevent HIV — on Wednesday, with manufacturer Gilead Sciences marketing it under the brand name Yeztugo.
FDA Approves Biannual HIV Prevention Shot
+3
JUN 18
JUN 18
Study: Highly-Affordable 'Vaccine-Like' HIV Drug Possible
+1
JUL 23 2024
JUL 2024
UN: AIDS Response 'Under Threat' Due to Stigmas
+7
NOV 28 2023
NOV 2023
Scientists Cut Out HIV DNA From Infected Cells
+6
MAR 20 2024
MAR 2024
FDA Finalizes New Blood Donation Guidelines
+8
MAY 11 2023
MAY 2023
Show More